Variant report
Variant | esv3422008 |
---|---|
Chromosome Location | chr17:15651752-15654600 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:17)
- CpG islands (count:367)
- Chromatin interactive region (count:1)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:17 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr17:15652603-15652660 | A549 | lung: | n/a | chr17:15652623-15652636 |
2 | CTCF | chr17:15653545-15653592 | GM13976 | blood: | n/a | n/a |
3 | CTCF | chr17:15653788-15653894 | LNCaP | prostate: | n/a | n/a |
4 | EBF1 | chr17:15651959-15652279 | GM12878 | blood: | n/a | n/a |
5 | EBF1 | chr17:15651996-15652216 | GM12878 | blood: | n/a | n/a |
6 | FOXA2 | chr17:15651919-15652290 | A549 | lung: | n/a | n/a |
7 | POLR2A | chr17:15652569-15652725 | A549 | lung: | n/a | n/a |
8 | POLR2A | chr17:15652594-15652680 | A549 | lung: | n/a | n/a |
9 | POLR2A | chr17:15652593-15652715 | A549 | lung: | n/a | n/a |
10 | REST | chr17:15653262-15653403 | GM12878 | blood: | n/a | n/a |
11 | SPI1 | chr17:15653736-15653931 | GM12878 | blood: | n/a | n/a |
12 | USF1 | chr17:15653388-15653705 | A549 | lung: | n/a | chr17:15653472-15653483 |
13 | USF1 | chr17:15653350-15653615 | HepG2 | liver: | n/a | chr17:15653472-15653483 |
14 | USF1 | chr17:15653412-15653567 | HepG2 | liver: | n/a | chr17:15653472-15653483 |
15 | USF1 | chr17:15653438-15653619 | A549 | lung: | n/a | chr17:15653472-15653483 |
16 | USF1 | chr17:15653421-15653756 | A549 | lung: | n/a | chr17:15653472-15653483 |
17 | USF1 | chr17:15653249-15653481 | GM12878 | blood: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr17:15653096-15653146 | HPAEpiC | pulmonary alveolar: | n/a |
2 | chr17:15653096-15653146 | HPAEpiC | pulmonary alveolar: | n/a |
3 | chr17:15653548-15653598 | SK-N-SH | brain: | n/a |
4 | chr17:15653548-15653598 | T-47D | breast: | n/a |
5 | chr17:15652715-15652765 | ProgFib | skin: | n/a |
6 | chr17:15652329-15652379 | NHBE | bronchial: | n/a |
7 | chr17:15653548-15653598 | PANC-1 | pancreas: | n/a |
8 | chr17:15653473-15653523 | NH-A | brain: | n/a |
9 | chr17:15653096-15653146 | SK-N-SH_RA | brain: | n/a |
10 | chr17:15653473-15653523 | HL-60 | blood: | n/a |
11 | chr17:15653473-15653523 | PrEC | prostate: | n/a |
12 | chr17:15652854-15652904 | AG04450 | lung: | fetal |
13 | chr17:15652329-15652379 | MCF10A-Er-Src | breast: | n/a |
14 | chr17:15653096-15653146 | HRE | kidney: | n/a |
15 | chr17:15653548-15653598 | NHDF-neo | bronchial: | n/a |
16 | chr17:15653548-15653598 | Caco-2 | colon: | n/a |
17 | chr17:15653548-15653598 | NT2-D1 | testis: | n/a |
18 | chr17:15653548-15653598 | HRE | kidney: | n/a |
19 | chr17:15652715-15652765 | HCT-116 | colon: | n/a |
20 | chr17:15652854-15652904 | SK-N-SH_RA | brain: | n/a |
21 | chr17:15653548-15653598 | HIPEpiC | eye: | n/a |
22 | chr17:15652715-15652765 | GM19239 | blood: | n/a |
23 | chr17:15653548-15653598 | LNCaP | prostate: | n/a |
24 | chr17:15652329-15652379 | T-47D | breast: | n/a |
25 | chr17:15652854-15652904 | HIPEpiC | eye: | n/a |
26 | chr17:15653548-15653598 | NH-A | brain: | n/a |
27 | chr17:15652854-15652904 | MCF10A-Er-Src | breast: | n/a |
28 | chr17:15653096-15653146 | PFSK-1 | brain: | n/a |
29 | chr17:15653096-15653146 | Jurkat | blood: | n/a |
30 | chr17:15652715-15652765 | HAEpiC | amniotic membrane: | n/a |
31 | chr17:15652854-15652904 | HPAEpiC | pulmonary alveolar: | n/a |
32 | chr17:15652715-15652765 | AG09319 | gingival: | n/a |
33 | chr17:15653548-15653598 | HCM | heart: | n/a |
34 | chr17:15652329-15652379 | RPTEC | kidney: | n/a |
35 | chr17:15652329-15652379 | AG09319 | gingival: | n/a |
36 | chr17:15652329-15652379 | HCPEpiC | choroid plexus: | n/a |
37 | chr17:15652715-15652765 | HCPEpiC | choroid plexus: | n/a |
38 | chr17:15652329-15652379 | AG09309 | skin: | n/a |
39 | chr17:15652854-15652904 | ECC-1 | luminal epithelium: | n/a |
40 | chr17:15652715-15652765 | RPTEC | kidney: | n/a |
41 | chr17:15652715-15652765 | HL-60 | blood: | n/a |
42 | chr17:15652715-15652765 | NT2-D1 | testis: | n/a |
43 | chr17:15653473-15653523 | T-47D | breast: | n/a |
44 | chr17:15653473-15653523 | HRPEpiC | eye: | n/a |
45 | chr17:15652854-15652904 | GM12892 | blood: | n/a |
46 | chr17:15652329-15652379 | IMR90 | lung: | fetal |
47 | chr17:15652854-15652904 | AG09309 | skin: | n/a |
48 | chr17:15653473-15653523 | ProgFib | skin: | n/a |
49 | chr17:15652329-15652379 | SKMC | muscle: | n/a |
50 | chr17:15652329-15652379 | GM12878 | blood: | n/a |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr17:15646677..15648283-chr17:15650856..15653224,2 | K562 | blood: |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-TRIM16-1 | chr17:15652017-15652629 | NONHSAT145866 |
2 | lnc-TRIM16-2 | chr17:15652075-15652506 | ENSG00000233002.2 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000233002 | TF binding region |
ENSG00000267227 | TF binding region |
ENSG00000233002 | CpG island |
ENSG00000267227 | CpG island |
ENSG00000233002 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs529326865 | chr17:15651755-15651756 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs146258166 | chr17:15651769-15651770 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs138917223 | chr17:15651780-15651781 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs565874904 | chr17:15651796-15651797 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs557794448 | chr17:15651829-15651830 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs141264529 | chr17:15651860-15651861 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs150759611 | chr17:15651863-15651864 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs553265946 | chr17:15651876-15651877 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs573045161 | chr17:15651883-15651884 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs557822350 | chr17:15651887-15651888 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs191400197 | chr17:15651904-15651905 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs555072343 | chr17:15651905-15651906 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs144165489 | chr17:15651919-15651920 | Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs59623326 | chr17:15651933-15651934 | Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs374782159 | chr17:15651934-15651935 | Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs58699635 | chr17:15651939-15651940 | Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs201170427 | chr17:15651943-15651944 | Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs377363012 | chr17:15651955-15651956 | Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs575272282 | chr17:15651967-15651968 | Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs544341740 | chr17:15651992-15651993 | Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs368114952 | chr17:15652020-15652021 | Weak transcription | TF binding regionChromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs74836444 | chr17:15652021-15652022 | Weak transcription | TF binding regionChromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs578232632 | chr17:15652025-15652026 | Weak transcription | TF binding regionChromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs540816376 | chr17:15652047-15652048 | Weak transcription | TF binding regionChromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs560885699 | chr17:15652075-15652076 | Weak transcription | TF binding regionChromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs529560660 | chr17:15652123-15652124 | Weak transcription | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs113579739 | chr17:15652147-15652148 | Weak transcription | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs562753665 | chr17:15652226-15652227 | Weak transcription | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs140039371 | chr17:15652297-15652298 | Weak transcription | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs79266960 | chr17:15652323-15652324 | Weak transcription | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs531569505 | chr17:15652365-15652366 | Weak transcription | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs189392990 | chr17:15652375-15652376 | Weak transcription | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs117551961 | chr17:15652381-15652382 | Weak transcription | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs113975036 | chr17:15652431-15652432 | Weak transcription | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs539288728 | chr17:15652456-15652457 | Weak transcription | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs374803978 | chr17:15652476-15652477 | Weak transcription | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs367944334 | chr17:15652512-15652513 | Weak transcription | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs3752012 | chr17:15652588-15652589 | Weak transcription | TF binding regionChromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs182020554 | chr17:15652589-15652590 | Weak transcription | TF binding regionChromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs28412540 | chr17:15652594-15652595 | Weak transcription | TF binding regionChromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | mRNA abundance |
41 | rs2529966 | chr17:15652604-15652605 | Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs535396375 | chr17:15652648-15652649 | Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
43 | rs555603689 | chr17:15652674-15652675 | Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
44 | rs4792665 | chr17:15652694-15652695 | Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
45 | rs537821969 | chr17:15652703-15652704 | Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
46 | rs557923920 | chr17:15652712-15652713 | Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
47 | rs190068217 | chr17:15652716-15652717 | Weak transcription Bivalent Enhancer | TF binding regionCpG islandChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
48 | rs11869390 | chr17:15652749-15652750 | Weak transcription Bivalent Enhancer | CpG islandChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
49 | rs560527272 | chr17:15652790-15652791 | Weak transcription Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs372713589 | chr17:15652794-15652795 | Weak transcription Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 17603634 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Wilms tumour | 21544195 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Chordoma | 21602918 | CNVD |
Miller-Dieker syndrome | 22283845 | CNVD |
Non-syndromic sensorineural hearing loss | 17457615 | CNVD |
Cancer | 22429812 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Breast cancer | 22028636 | CNVD |
Breast cancer | 20837533 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
colon cancer | 17210682 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Chronic lymphocytic leukemia | 17971485 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Breast cancer | 16461572 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Breast cancer | 17133270 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Moyamoya disease | 22323933 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20724749 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Colorectal cancer | 21645411 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
HIV/AIDS | 17953491 | CNVD |
HIV/AIDS | 20877625 | CNVD |
Immune disease | 21076436 | CNVD |
Rheumatoid arthritis | 17953491 | CNVD |
Type 1 diabetes | 17953491 | CNVD |
HIV/AIDS | 15637236 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Neurofibromatosis | 18196300 | CNVD |
Adenoid cystic carcinoma | 18332873 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21509527 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Autism | 17322880 | CNVD |
Hereditary neuropathy with liability to pressure palsy | 19521722 | CNVD |
Schizophrenia | 19571808 | CNVD |
Schizophrenia | 19955444 | CNVD |
Charcot-marie-tooth disease | 18787571 | CNVD |
Breast cancer | 20409316 | CNVD |
Autism | 18414403 | CNVD |
Breast cancer | 17001317 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Peripheral neuropathy | 21193943 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 22958593 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Charcot-marie-tooth disease | 16463004 | CNVD |
Osteosarcoma | 22292074 | CNVD |
Charcot | 16760730 | CNVD |
Mental retardation | 17901693 | CNVD |
ovarian endometriomas | 16273235 | CNVD |
Breast cancer | 21858162 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 17142309 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Autism | 22102821 | CNVD |
Gastric cancer | 18160780 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:15648800-15652800 | Weak transcription | Ovary | ovary |
2 | chr17:15651400-15651800 | Enhancers | Primary monocytes fromperipheralblood | blood |
3 | chr17:15651400-15651800 | Enhancers | Monocytes-CD14+_RO01746 | blood |
4 | chr17:15652600-15653000 | Bivalent Enhancer | Monocytes-CD14+_RO01746 | blood |
5 | chr17:15652800-15653000 | Bivalent Enhancer | Foreskin Keratinocyte Primary Cells skin03 | Skin |
6 | chr17:15652800-15653000 | Flanking Active TSS | Ovary | ovary |
7 | chr17:15652800-15653000 | Flanking Active TSS | Psoas Muscle | Psoas |
8 | chr17:15652800-15653200 | Enhancers | Placenta Amnion | Placenta Amnion |
9 | chr17:15652800-15653400 | Active TSS | Right Ventricle | heart |
10 | chr17:15653000-15654000 | Active TSS | Ovary | ovary |